-
Clinical, Cosmetic and Investigational Dermatology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Role of telavancin in treatment of skin and skin structure infections
Review
(2093) Views (666) Full article downloads
Authors: Joseph Bonkowski, Anne R Daniels, William J Peppard
Published Date October 2010
Volume 2010:3 Pages 127 - 133
DOI: http://dx.doi.org/10.2147/CCID.S9027
Joseph Bonkowski1, Anne R Daniels2, William J Peppard21University of Wisconsin-Madison, Madison, WI, USA; 2Froedtert Hospital, Milwaukee, WI, USA
Abstract: Skin and skin structure infections (SSSIs) are a common diagnosis encountered by ambulatory and inpatient practitioners across the country. As the SSSIs become more complicated, they require increased health care resources and often involve hospitalization and intravenous antimicrobials. Complicated SSSIs are caused by a variety of pathogens, including Gram-positive, Gram-negative, and anerobic bacteria. Empiric broad-spectrum antibiotic coverage is warranted, taking into account area disease-state epidemiology and antimicrobial susceptibility data. Telavancin is an antimicrobial agent with a broad Gram-positive spectrum of activity which was recently approved for the treatment of SSSIs. It may especially benefit patients with resistant organisms, such as methicillin-resistant Staphylococcus aureus. This article reviews telavancin and its pharmacology, efficacy, and safety data to enhance the practitioner’s knowledge base on the appropriateness of telavancin for the treatment of SSSIs.
Keywords: skin and skin structure infections, telavancin, methicillin-resistant Staphylococcus aureus
Other articles by Dr William Peppard
Readers of this article also read:
Biologics in the management of psoriasis
Dermal benefits of topical D-ribose
Novel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol
Botulinum toxin type A for the management of glabellar rhytids
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Erratum
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
Eponyms in dermatology literature linked to Japan
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
- Update on the management of chronic eczema: new approaches and emerging treatment options
- Anti-inflammatory effects of a topical preparation containing nicotinamide, retinol, and 7-dehydrocholesterol in patients with acne: a gene expression study
- Management of superficial basal cell carcinoma: focus on imiquimod




